AI assistant
Keros Therapeutics, Inc. — Director's Dealing 2021
Feb 16, 2021
32602_dirs_2021-02-16_3fce099e-23fa-4d3a-b4b4-a5e2eaac8702.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Keros Therapeutics, Inc. (KROS)
CIK: 0001664710
Period of Report: 2021-02-11
Reporting Person: Lachey Jennifer (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-11 | Common Stock | M | 5300 | $0.30 | Acquired | 33291 | Direct |
| 2021-02-11 | Common Stock | S | 447 | $62.85 | Disposed | 32844 | Direct |
| 2021-02-11 | Common Stock | S | 1460 | $63.74 | Disposed | 31384 | Direct |
| 2021-02-11 | Common Stock | S | 1272 | $64.93 | Disposed | 30112 | Direct |
| 2021-02-11 | Common Stock | S | 1845 | $65.99 | Disposed | 28267 | Direct |
| 2021-02-11 | Common Stock | S | 262 | $67.05 | Disposed | 28005 | Direct |
| 2021-02-11 | Common Stock | S | 14 | $68.05 | Disposed | 27991 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-11 | Employee Stock Option (right to buy) | $0.30 | M | 5300 | Disposed | 2028-03-25 | Common Stock (5300) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.33 to
$63.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and
Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in
footnotes (2), (3), (4), (5) and (6).
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.345 to $64.34 inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.345 to $65.34 inclusive.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.355 to $66.24 inclusive.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.69 to $67.635 inclusive.
F7: Immediately exercisable.